medigraphic.com
ISSN 1561-2945 (Impreso)

2012, Número 2

<< Anterior Siguiente >>

Revista Cubana de Cirugía 2012; 51 (2)


Adenocarcinoma hepatoide gástrico

Guerra MJL, Guarnaluce BR

Idioma: Español
Referencias bibliográficas: 33
Paginas:
Archivo PDF: 74.54 Kb.


RESUMEN

El adenocarcinoma hepatoide gástrico es un tumor maligno que tiene una morfología que se asemeja al carcinoma hepatocelular, y algunos poseen alfa feto proteína inmunorreactiva. Es de mal pronóstico, agresivo y letal. Se presenta el caso de una paciente de 84 años de edad que padecía un adenocarcinoma gástrico variedad hepatoide. El tratamiento consistió en una gastrectomía subtotal distal ampliada con linfadenectomía tipo D2. El objetivo de este trabajo es la presentación de un caso poco frecuente y la revisión de la literatura sobre este tema.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Borrman R. Geschwülste des magens. In: von Henke FU, Lurbash O, eds. Handbush der speziellen pathologischen antomie. Berlin: Verlag von Julius Springer; 1926. p. 864-71.

  2. Sobin LH, Wittekind CM. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002. p. 178-83.

  3. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 2nd. English Edition. Gastric Cancer. 1998;1:10-24.

  4. Bourreille J, Metayer P, Sauger F, Fondimare A. Existence d'alpha fetoproteine au cour d'un cancer secondaire du foie d'origine gastrique. Als Press Med. 1970;78:1277-8.

  5. Ishikura H, Fukasawa Y, Ogasawara K, Natori T, Tsukada Y, Aizawa M. An AFP-producing gastric carcinoma with features of hepatic differentiation: a case report. Cancer. 1985;56:840-8.

  6. Ishikura H, Kirimoto K, Shamoto M, Miyamoto Y, Ymagiwa H, Itho T, Aizawa M. Hepatoid adenocarcinoma of the stomach: an analysis of seven cases. Cancer. 1986;58:119-26.

  7. McIntire KR, Waldmann TA, Moertel CG, Go WLW. Serum alpha-fetoprotein in patients with neoplastic carcinomas. N Engl J Med. 1971;285:1060-1.

  8. Takanahashi Y, Mai O, Ogino T, Ueda H, Sawaguchi K, Ueno M. Clinicopathological study of AFP-producing gastric cancer. Significance of AFP in gastric cancer. J Jpn Surg Soc. 1987;88:696-700.

  9. Mori M, Ambe K, Adachi Y, Yakeishi Y, Nakamura K, Hachitanda Y, et al. Pronostic value of immunohistochemical identified CEA, AFP, and S- Chen, Mi 100 protein positive cells in gastric carcinoma. Cancer. 1988;62:534-40.

  10. Díez Redondo P, Torrego García JC. Carcinoma hepatoide gástrico. Rev Esp Enferm Dig. 2005;97(5):380-1.

  11. Sheng Zhang Wang, Yi-Hui Xue, Yu-Peng Wang. Cerebral metastasis from hepatoid adenocarcinoma of the stomach. World J Gastroenterol. 2007 November 21;13(43):5787-93.

  12. Takanahashi Y, Mai O, Ogino T, Ueda H, Sawaguchi K, Ueno M. Clinicopathological study of AFP-producing gastric cancer. Significance of AFP in gastric cancer. J Jpn Surg Soc. 1987;88:696-700.

  13. Hayashi Y, Takanashi Y, Ohsawa H, Ishii H, Nakatani Y. Hepatoid adenocarcinoma in the lung. Lung Cancer. 2002;38:211-4.

  14. Shih NN, Tsung JS, Yang AH, Tsou MH, Cheng TY. A unique pancreatic tumor with exclusive hepatocytic differentiation. Ann Clin Lab Sci. 2006;36:216-21.

  15. Lazaro J, Rubio D, Repolles M, Capote L. Hepatoid carcinoma of the ovary and management. Acta Obstet Gynecol Scand. 2007;86(4):498-9.

  16. Takeuchi K, Kitazawa S, Hamanishi S, Inagaki M, Murata K. A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman. Int J Gynecol Cancer. 2006;16:1442-5.

  17. Lopez-Beltran A, Luque RJ, Quintero A, Requena MJ, Montironi R. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch. 2003 Apr;442(4):381-7.

  18. Vardaman C, Albores-Saavedra J. Clear cell carcinomas of the gallbladder and extrahepatic bile ducts. Am J Surg Pathol. 1995;19:91-9.

  19. Ishikura H, Ishiguro T, Enatsu C, Fujii H, Kakuta Y, Kanda M, et al. Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment. Cancer. 1991;67:3051-6.

  20. Foschini MP, Baccarini P, Dal Monte PR, Sinard J, Eusebi V, Rosai J. Albumin gene expression in adenocarcinomas with hepatoid differentiation. Virchows Arch. 1998 Dec;433(6):537-41.

  21. Supriatna Y, Kishimoto T, Uno T, Nagai Y, Ishikura H. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA. Pathology. 2005 Jun;37(3):211-5.

  22. Gálvez-Muñoz E, Gallego-Plazas J, Gonzalez-Orozco V, Menarguez-Pina F, Ruiz-Maciá JA, Morcillo MA. Hepatoid adenocarcinoma of the stomach a different histology for not so different gastric adenocarcinoma: a case report. Int Semin Surg Oncol. 2009;6:13.

  23. Maitra A, Murakata LA, Albores-Saavedra J. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol. 2001 May;115(5):689-94.

  24. Iso Y, Sawada T, Shimoda M, Rokkaku K, Ohkura Y, Kubota K. Solitary AFP and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis. Hepatogastroenterology. 2005 Nov-Dec;52(66):1930-2.

  25. Ushiku T, Uozaki H, Shinozaki A, Ota S, Matsuzaka K, Nomura S, et al. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas. Cancer Sci. 2009 Apr;100(4):626-32.

  26. Kodama T, Kameya T, Hirota T, Shimosato Y, Ohkura H, Mukojima T, et al. Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases. Cancer. 1981;48:1647-55.

  27. Kang GH, Kim YI. Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes. Virchows Arch. 1998;432:85-7.

  28. Fujii H, Ichikawa K, Takagaki T, Nakanishi Y, Ikegami M, Hirose S, et al. Genetic evolution of á fetoprotein producing gastric cancer. J Clin Pathol. 2003 December;56(12):942-9.

  29. Koide N, Nishio A, Igarashi J, Kajikawa S, Adachi W, Amano J. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. Am J Gastroenterol. 1999;94:1658-63.

  30. Takahashi T, Kochi M, Kanamori N, Kaiga T, Funada T, Fujii M, et al. Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case. Gan To Kagaku Ryoho. 2009 Nov;36(11):1885-8.

  31. Kochi M, Fujii M, Kaiga T, Takahashi T, Morishita Y, Kobayashi M, et al. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology. 2004;66(6):445-9.

  32. Meguro E, Kimura T, Noda Y, Matsumoto Y, Irinoda T, Hayakawa Y, et al. A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases. Gan To Kagaku Ryoho. 2007 Feb;34(2):249-52.

  33. Kakeji Y, Morita M, Maehara Y. Strategies for treating liver metastasis from gastric cancer. Surg Today. 2010 Apr;40(4):287-94.




2020     |     www.medigraphic.com